STOCK-BASED COMPENSATION (Tables)

6 Months Ended

Jun. 30, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of weighted average assumptions

During the six months ended June 30, 2017, the Company estimated the fair value of stock options granted using the Black-Scholes option pricing model with the following weighted average assumptions: 

	June 30, 2017
Weighted average risk free interest rate		1.89% — 2.14	%
Weighted average life (in years)		5.0
Volatility		98.41% — 98.55	%
Expected dividend yield		0	%
Weighted average grant-date fair value per share of options granted	$	0.45

Schedule of options outstanding exercise price

The options outstanding as of June 30, 2017, have been classified by exercise price, as follows: 

Outstanding							Exercisable
			Weighted
			Average		Weighted				Weighted
			Remaining		Average				Average
Exercise	Number		Contractual		Exercise		Number		Exercise
Price	Outstanding		Life (Years)		Price		Exercisable		Price
$0.60 - $0.79		2,375,000		9.38	$	0.66		1,246,667	$	0.66
$1.10 - $1.32		25,000		6.35	$	1.28		15,000	$	1.25
$1.51 - $1.69		441,000		5.36	$	1.61		378,500	$	1.60
$0.60 - 1.69		2,841,000		8.73	$	1.10		1,640,167	$	0.88

Schedule of stock-based compensation expense

The total stock-based compensation expense related to stock options and restricted stock awards issued pursuant to the Plans to the Company’s employees, consultants and directors, included in reported net loss for the three and six months ended June 30, 2017 and 2016, is comprised as follows: 

	Three Months Ended				Six Months Ended
	June 30, 2017		June 30, 2016		June 30, 2017		June 30, 2016
Cost of revenues	$	3	$	2	$	4	$	4
Engineering and product development		6		1		13		2
Selling and marketing		6		4		11		8
General and administrative		557		36		668		73
Total stock-based compensation	$	572	$	43	$	696	$	87

Schedule of option activity under the company's stock option

A summary of option activity under the Company's stock option plans as of June 30, 2017, and changes during the six months ended are as follows:

				Outstanding Options
								Weighted
						Weighted		Average
	Shares					Average		Remaining		Aggregate
	Available			Number		Exercise		Contractual		Intrinsic
	for Grant			of Shares		Price		Life (years)		Value
December 31, 2016		3,247,630			2,331,000	$	0.83		9.08	$	0
Restricted stock awards		(956,153	)
Grants		(510,000	)		510,000	$	0.60
June 30, 2017		1,781,477			2,841,000	$	0.81		8.73	$	148